FDA Approves New Antibacterial Combination for Treating Certain Infections in Adults
July 17th 2019Merck’s antibacterial drug injection—a combination of imipenem, cilastatin and relebactam (Recarbrio) —is indicated for adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).
Read More
Puma Submits sNDA for Neratinib Combo Therapy for HER2-Positive Metastatic Breast Cancer
July 12th 2019Puma Biotechnology submitted a supplemental New Drug Application to the FDA for neratinib (Nerylnx) in combination with capecitabine for the treatment of patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
Read More